Literature DB >> 6465184

Torsade de Pointe. Malignant cardiac arrhythmia induced by amantadine poisoning.

M Sartori, C M Pratt, J B Young.   

Abstract

A 37-year-old woman took 2.5 g of amantadine hydrochloride in a suicide attempt. Subsequently, cardiopulmonary arrest developed and was treated successfully. During the arrest and over the subsequent 48 hours, malignant tachyarrhythmias were manifested by torsade de pointe and repeated episodes of ventricular fibrillation. Therapy with adrenergic agents such as isoproterenol and particularly dopamine seemed to exacerbate the ventricular tachyarrhythmias. The patient subsequently died of aspiration pneumonia and respiratory distress, and postmortem examination revealed a normal cardiovascular system. It appears that the dopaminergic activity of amantadine has potential for induction of malignant arrhythmias, particularly in the face of adrenergic agents such as dopamine and isoproterenol. This previously unreported observation needs to be considered in critically ill patients with amantadine toxicity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6465184     DOI: 10.1016/0002-9343(84)90728-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

Review 1.  Safety and Tolerability of Pharmacotherapies for Parkinson's Disease in Geriatric Patients.

Authors:  Martin Klietz; Stephan Greten; Florian Wegner; Günter U Höglinger
Journal:  Drugs Aging       Date:  2019-06       Impact factor: 3.923

2.  QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadine.

Authors:  Alex F Manini; Dara Raspberry; Robert S Hoffman; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2007-12

Review 3.  Drug effects on the electrocardiogram. A review of their clinical importance.

Authors:  J D Symanski; L S Gettes
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

Review 4.  Efficacy and safety of amantadine for the treatment of L-DOPA-induced dyskinesia.

Authors:  Santiago Perez-Lloret; Olivier Rascol
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

5.  Cardiotoxicity after massive amantadine overdose.

Authors:  Michael Schwartz; Manish Patel; Ziad Kazzi; Brent Morgan
Journal:  J Med Toxicol       Date:  2008-09

Review 6.  Physical assessment and differential diagnosis of the poisoned patient.

Authors:  K R Olson; P R Pentel; M T Kelley
Journal:  Med Toxicol       Date:  1987 Jan-Feb

Review 7.  QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards.

Authors:  M Zehender; S Hohnloser; H Just
Journal:  Cardiovasc Drugs Ther       Date:  1991-04       Impact factor: 3.727

Review 8.  Drug-induced torsade de pointes. Incidence, management and prevention.

Authors:  T S Faber; M Zehender; H Just
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

9.  An EGFP Knock-in Zebrafish Experimental Model Used in Evaluation of the Amantadine Drug Safety During Early Cardiogenesis.

Authors:  Shi Ouyang; Wu-Ming Qin; Yu-Juan Niu; Yong-He Ding; Yun Deng
Journal:  Front Cardiovasc Med       Date:  2022-04-05

10.  Antiviral agents against respiratory viruses.

Authors:  Cecile L Tremblay
Journal:  Clin Microbiol Newsl       Date:  2001-12-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.